Biolife stock.

The BioLife Solutions stock price fell by -6.21% on the last day (Wednesday, 18th Oct 2023) from $12.39 to $11.62. During the last trading day the stock fluctuated 5.35% from a day low at $11.59 to a day high of $12.21. The price has fallen in 5 of the last 10 days and is down by -14.5% for this period. Volume fell on the last day along with ...

Biolife stock. Things To Know About Biolife stock.

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Biolife Solutions share forecasts, stock quote and buy / sell signals below. According to present data Biolife Solutions's BLFS shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Evogene Ltd. -0.32%. $32.76M. BLFS | Complete BioLife Solutions Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.BioLife Solutions Probability Of Bankruptcy is currently at 1.00%. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability …Discover historical prices for BLFE stock on Yahoo Finance. View daily, weekly or monthly format back to when BioLife Sciences Inc. stock was issued.

Evogene Ltd. -0.32%. $32.76M. BLFS | Complete BioLife Solutions Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Biolife Solutions Inc (NASDAQ:BLFS) has a beta value of 1.60 and has seen 2.24 million shares traded in the last trading session. The company, currently valued at $596.91M, closed the last trade at $13.25 per share which meant it gained $0.88 on the day or 7.11% during that session. The BLFS stock ...Four times named as one of the top 100 Companies to work for in Washington state (2022, 2020, 2015, and 2013), BioLife Solutions Inc. is a multi-platform provider of bioproduction tools and services to the cell and gene therapy and …

BLFS Stock 12 Months Forecast. $23.25. (128.61% Upside) Based on 6 Wall Street analysts offering 12 month price targets for BioLife Solutions in the last 3 months. The average price target is $23.25 with a high forecast of $26.00 and a low forecast of $20.00. The average price target represents a 128.61% change from the last price of $10.17.BOTHELL, Wash., Nov. 4, 2021 / PRNewswire / -- BioLife Solutions, Inc. (the "Company") (Nasdaq: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced changes to its executive management team, effective immediately.Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...Chg %. Market Cap. Evogene Ltd. -1.07%. $30.17M. BLFS | Complete BioLife Solutions Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full …

Nov 28, 2023 · Biolife Solutions Inc stock received a consensus recommendation rating of a Buy, based on a mean score of 1.25. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended BLFS as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight.

First, BioLife Solutions, Inc. stock is trading at 1.95x book value of equity, which may or may not represent a value proposition. However, it should also be noted the breakdown of its book value ...

Casdin Capital now owns about 19.5% of BioLife Solutions' stock. BioLife Chief Financial Officer Troy Wichterman said the company didn't have any insight to provide beyond the publicly available ...Historical daily share price chart and data for BioLife Solutions since 1992 adjusted for splits and dividends. The latest closing stock price for BioLife Solutions as of December 01, …BioLife Solutions Inc stock performance at a glance. Check BioLife Solutions Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. Stock gifts should include both the number of stocks given and the stock name. It should not include the fair market value of the stock. Donations of cryptocurrency should include the amount donated and the type of currency. For gifts of property, the physical address/location should be marked on the letter so the IRS can match it with any ...Four times named as one of the top 100 Companies to work for in Washington state (2022, 2020, 2015, and 2013), BioLife Solutions Inc. is a multi-platform provider of bioproduction tools and services to the cell and gene therapy and broader biopharma markets. Learn more.

Dec 18, 2022 · Conestoga Capital Advisors highlighted stocks like BioLife Solutions, Inc. (NASDAQ:BLFS) in its Q3 2022 investor letter. Headquartered in Bothell, Washington, BioLife Solutions, Inc. (NASDAQ:BLFS ... Octapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disordersBioLife Solutions, Inc. (NASDAQ:BLFS) Major Shareholder Casdin Partners Master Fund, L Acquires 58,465 Shares marketbeat.com - August 11 at 7:16 PM: Analysts Are Bullish on Top Healthcare Stocks: BioLife Solutions (BLFS), Synlogic (SYBX) markets.businessinsider.com - August 11 at 6:40 PMWebDec 4, 2023 · Rhumbline Advisers decreased its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 8.1% in the second quarter, Holdings Channel.com reports. The institutional investor owned 80,251 shares of the medical equipment provider’s stock after selling 7,097 shares during the period. Rhumbline Advisers’ holdings in BioLife Solutions were worth $1,774,000 as of its most recent […] BioLife Solutions (NASDAQ:BLFS) recently announced preliminary results for FY2017. The company expects full-year 2017 revenue in the range of $11 million, which would be a gain of 34% from 2016. The solid growth in its revenue was driven by strong results from its worldwide distributors and higher sales to customers in the regenerative …CI. BioLife Sciences Inc. Announces the Launch of BioLife Copper-Infused Microfiber Towels. 2022. CI. BioLife Sciences Inc. announced that it expects to receive $20 million in funding. 2022. CI. BioLife Sciences Inc. Reports Earnings Results for the First Quarter Ended February 28, 2022. 2022.$12.75. As on 28-Nov-2023 16:00 EST. up-down-arrow $-0.69 • -5.13% · Prev Close info. $13.44 · Day's Open info. $13.38 · Today's High info. $13.55 · Today's Low ...

See the latest Biolife Sciences Inc stock price (BLFE:PINX), related news, valuation, dividends and more to help you make your investing decisions.

The estimated net worth of Aby J. Mathew is at least $3.52 million as of November 13th, 2023. Dr. Mathew owns 275,726 shares of BioLife Solutions stock worth more than $3,521,021 as of November 18th. This net worth estimate does not reflect any other assets that Dr. Mathew may own.Dec 22, 2021 · As follows, BioLife procured $29.2M compared to $10.8M for the same period a year prior. As such, this represents a 200% year-over-year (YOY) growth. Of the total revenue, the bulk comes from ... Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.BLFS. BioLife Solutions, Inc. 11.83. +1.05. +9.74%. The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of ...Nov 24, 2023 · The BioLife Solutions stock price fell by -6.21% on the last day (Wednesday, 18th Oct 2023) from $12.39 to $11.62. During the last trading day the stock fluctuated 5.35% from a day low at $11.59 to a day high of $12.21. The price has fallen in 5 of the last 10 days and is down by -14.5% for this period. Volume fell on the last day along with ... Find Biolife Plasma stock images in HD and millions of other royalty-free stock photos, 3D objects, illustrations and vectors in the Shutterstock collection ...

Mar 2, 2023 · BOTHELL - BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ('CGT') and broader biopharma markets, today announced the launch of Ultraguard, the first ever non-toxic, non-hazardous and non-flammable -70-degreeC phase change material ('PCM'), for ultra-low temperature (ULT) protection.

BioLife shares outstanding (as of March 19, 2021) 33,401,359 Merger consideration percentage 19.9 % Merger consideration shares 6,646,870 less: Merger consideration shares withheld to satisfy outstanding GCI stockholder obligations to GCI 10,400 Subtotal 6,636,470 BioLife stock price (as of May 3, 2021) $ 35.07 Value of issued shares $ …

Operating income, quarterly and annual stats of BIOLIFE SOLUTIONS DL ... Stock Screener · Forex Screener · Crypto Pairs Screener · Crypto Coins Screener ...BANNOCKBURN, Ill., March 27, 2023--BioLife Plasma Services, part of the global biopharmaceutical company Takeda, today announced the opening of its 200th plasma donation center in the United ...Track Biolife Solutions Inc (BLFS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBioLife was founded as Trans Time Medical Products in 1987 and went public in 1989, raising net proceeds of $4.6 million at $105 per share (after giving effect to 1-for-five (2000) and 1-for-14 ...Posted 3:27:21 PM. By clicking the "Apply" button, I understand that my employment application process with Takeda…See this and similar jobs on LinkedIn.Discover historical prices for BLFS stock on Yahoo Finance. View daily, weekly or monthly format back to when BioLife Solutions, Inc. stock was issued.Chief Quality Officer Of Biolife Solutions Trades $760K In Company Stock. (Benzinga) Sep-20-21 08:00AM. BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors. (PR Newswire) BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings ...WebNov 30, 2023 · BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. Track Biolife Solutions Inc (BLFS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBioLife Solutions has signed a 10-year deal to supply Kite with its CryoStor media for freezing samples, which Kite will use to transport materials for its next-generation cancer treatments.

Sitemap. A high-level overview of BioLife Solutions, Inc. (BLFS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …The stock information provided is for informational purposes only and is not intended for trading purposes. BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors.Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Instagram:https://instagram. jnbsxdelta tickercrisper tickerfisker stock news Sexton's 2021 revenue contribution is expected to be approximately $2 million, based on an anticipated closing date of September 1st. BioLife 2021 total revenue is expected to be in a range of ...Web stock tracking websitefinancial planner columbus ohio B. Riley FBR analyst Marc Wiesenberger resumed coverage of BioLife stock with a Buy rating and a price target of $27 per share, representing a 94.6% premium to Thursday's closing price. As cell ...BioLife Solutions, Inc. (“BioLife”, “us”, “we”, “our”, or the “Company”) is a developer, manufacturer, and supplier of a portfolio of bioproduction tools and services including proprietary biopreservation media, automated cell processing fill machines, closed system cryogenic vials, human platelet lysate (“hPL”) growth ... online real estate investing platforms BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced ...BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Biolife Solutions share forecasts, stock quote and buy / sell signals below. According to present data Biolife Solutions's BLFS shares and potentially its market environment have been in bearish cycle last 12 months (if exists).